Press Releases

Swiss-based Debiopharm co-invests in the future of cell therapies on a chip through the latest $25 million Series A round…

Nucleai and Debiopharm Launch Research Collaboration Utilizing Nucleai’s AI-Powered Biomarker Platform

Belgian scale-up Oncomfort raises €10 million in Series A funding co-led by Debiopharm and Crédit Mutuel Innovation to further develop…

Nucleai Secured $6.5m Series-A Initial Closing Led by Debiopharm to Advance Ai-Powered Precision Oncology Platform

Acquisition of Debiopharm’s Investment Portfolio Company Kaiku Health Broadens Patient Access to Digital Oncology Intervention

Novadiscovery raises series A financing to scale its in silico clinical trial platform – Debiopharm leads the round with EUR…

Kaiku Health raises €4.4 million series A financing to accelerate its digital therapeutics pipeline led by Debiopharm and Tesi

BC Platforms Closes USD $10 million Series B Financing led by Debiopharm and Tesi to accelerate knowledge platform development

Debiopharm Innovation Fund: the New Name and Investment Strategy of Debiopharm Diagnostics